| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
DiaMedica Therapeutics Inc.
13G/A
DMAC · 25253X207
|
16.3% |
7/30/2025
Event 7/23/2025
|
||||
| TomEnterprise AB | 16.3% | |||||
| TomEnterprise Private AB | 16.3% | |||||
| Thomas von Koch | 16.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.